Publications

Export 113 results:
Sort by: Author Title Type [ Year  (Desc)]
unknown year
, , , unknown year. Abstract
n/a
2022
Vitale, A., F. Della Casa, G. Ragab, I. A. Almaghlouth, G. Lopalco, R. M. Pereira, S. Guerriero, M. Govoni, P. P. Sfikakis, R. Giacomelli, et al., "Development and implementation of the AIDA International Registry for patients with Behçet’s disease", Internal and Emergency Medicine: Springer Science and Business Media Deutschland GmbH, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Della Casa, F., A. Vitale, R. M. Pereira, S. Guerriero, G. Ragab, G. Lopalco, M. Cattalini, I. Mattioli, P. Parronchi, M. P. Paroli, et al., "Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis", Ophthalmology and Therapy, vol. 11, issue 2: Adis, pp. 887 - 897, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Casa, F. D., A. Vitale, S. Guerriero, J. Sota, R. Cimaz, G. Ragab, P. Ruscitti, R. M. R. Pereira, F. Minoia, E. Del Giudice, et al., "Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis", Ophthalmology and Therapy, vol. 11, issue 2: Adis, pp. 899 - 911, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Vitale, A., F. Della Casa, G. Lopalco, R. M. Pereira, P. Ruscitti, R. Giacomelli, G. Ragab, F. La Torre, E. Bartoloni, E. Del Giudice, et al., "Development and Implementation of the AIDA International Registry for Patients With Still's Disease", Frontiers in Medicine, vol. 9: Frontiers Media S.A., 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Della Casa, F., A. Vitale, G. Lopalco, P. Ruscitti, F. Ciccia, G. Emmi, M. Cattalini, E. Wiesik-Szewczyk, M. C. Maggio, B. Ogunjimi, et al., "Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases", Frontiers in Medicine, vol. 9: Frontiers Media S.A., 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Moawad, P., R. Shamma, D. Hassanein, G. Ragab, and O. El Zawahry, "Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome", European Journal of Ophthalmology, vol. 32, issue 1: SAGE Publications Ltd, pp. 673 - 679, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Beshlawy, A. E., A. E. R. Zekri, M. S. Ramadan, Y. M. M. Selim, A. Abdel-Salam, M. T. Hegazy, L. Ragab, C. Gaggiano, L. Cantarini, and G. Ragab, "Genotype–phenotype associations in familial Mediterranean fever: a study of 500 Egyptian pediatric patients", Clinical Rheumatology, vol. 41, issue 5: Springer Science and Business Media Deutschland GmbH, pp. 1511 - 1521, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Goubran, H., G. Ragab, and W. Sabry, "Metabolism-mediated thrombotic microangiopathy and B12", Vitamins and Hormones, vol. 119: Academic Press Inc., pp. 441 - 455, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Goubran, H., J. Seghatchian, W. Sabry, G. Ragab, and T. Burnouf, "Platelet and extracellular vesicles in COVID-19 infection and its vaccines", Transfusion and Apheresis Science, vol. 61, issue 3: Elsevier Ltd, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Fayed, A., M. T. Hegazy, L. Biard, M. Vieira, T. El Shabony, D. Saadoun, M. Casato, M. Visentini, G. Ragab, and P. Cacoub, "Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis after Sustained Viral Response after Interferon-Free Direct-Acting Antivirals", American Journal of Gastroenterology, vol. 117, issue 4: Wolters Kluwer Health, pp. 627 - 636, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Goubran, H., J. Stakiw, J. Seghatchian, G. Ragab, and T. Burnouf, "SARS-CoV-2 and cancer: The intriguing and informative cross-talk", Transfusion and Apheresis Science: Elsevier Ltd, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Elbendary, A., M. R. E. Abdel-Halim, and G. Ragab, "Updates in cutaneous manifestations of systemic vasculitis", Current opinion in rheumatology, vol. 34, issue 1: NLM (Medline), pp. 25 - 32, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
2021
Gaggiano, C., D. Rigante, J. Hernández-Rodríguez, A. Vitale, M. Tarsia, A. Soriano, G. Lopalco, F. Iannone, M. Abdel Jaber, R. Giacomelli, et al., "Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network", Therapeutic Advances in Musculoskeletal Disease, vol. 13: SAGE Publications Ltd, 2021. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Sota, J., D. Rigante, R. Cimaz, M. Cattalini, M. Frassi, R. Manna, L. L. Sicignano, E. Verrecchia, E. Aragona, M. C. Maggio, et al., "Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: Observational study from the International AIDA Registry", Rheumatology (United Kingdom), vol. 60, issue 12: Oxford University Press, pp. 5705 - 5712, 2021. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
REFAAT, M., A. M. Abdullatif, M. M. Hamza, T. A. Macky, M. - S. H. El-Agha, G. Ragab, and M. M. Soliman, "MONTHLY INTRAVITREAL INFLIXIMAB IN BEHÇET'S DISEASE ACTIVE POSTERIOR UVEITIS: A Long-Term Safety Study", Retina (Philadelphia, Pa.), vol. 41, issue 8: NLM (Medline), pp. 1739 - 1747, 2021. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Treppo, E., L. Quartuccio, G. Ragab, and S. De Vita, "Rheumatologic manifestations of Hepatitis C Virus", Minerva Medica, vol. 112, issue 2: Edizioni Minerva Medica, pp. 201 - 214, 2021. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Sota, J., D. Rigante, R. Cimaz, M. Cattalini, M. Frassi, R. Manna, L. L. Sicignano, E. Verrecchia, E. Aragona, and M. C. Maggio, "Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry", Rheumatology, 2021. Abstract
n/a
2020
Ragab, G., M. T. Hegazy, M. Ali, M. R. E. Abdel-Halim, and X. Puéchal, "Three Patterns of Cutaneous Involvement in Granulomatosis with Polyangiitis", Journal of Advanced Research, vol. 24: Elsevier B.V., pp. 311 - 315, 2020. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., M. T. Hegazy, V. Codullo, M. Mattar, and J. Avouac, "Anticoagulation in Autoimmune Rheumatic Diseases", Precision Anticoagulation Medicine: Springer, Cham, pp. 159-179, 2020. Abstract
n/a
Mattar, M., H. M. A. Ahmed, and G. Ragab, "Antiphospholipid Syndrome", Precision Anticoagulation Medicine: Springer, Cham, pp. 181-201, 2020. Abstract
n/a
Pusiol, A., F. Marzona, D. Cucchiaro, L. Castriotta, S. Usai, M. Narduzzi, C. Pilotto, I. Liguoro, R. Tosolini, and E. Passone, "Articles online first", Minerva Pediatrica, 2020. Abstract
n/a
Refaat, M., A. M. Abdullatif, M. M. Hamza, T. A. Macky, M. H. El-Agha, G. Ragab, and M. M. Soliman, "Monthly Intravitreal Infliximab in Behçet's Disease Active Posterior Uveitis: A Long-Term Safety Study.", Retina (Philadelphia, Pa.), 2020. Abstract
n/a
Treppo, E., L. Quartuccio, G. Ragab, and S. De Vita, "Rheumatologic manifestations of Hepatitis C Virus.", Minerva Medica, 2020. Abstract
n/a
Ragab, G., M. T. Hegazy, M. Ali, M. R. E. Abdel-Halim, and X. Puéchal, "Three Patterns of Cutaneous Involvement in Granulomatosis with Polyangiitis", Journal of Advanced Research, vol. 24: Elsevier, pp. 311-315, 2020. Abstract
n/a
2019
Cacoub, P., S. N. Si ahmed, Y. ferfar, S. Pol, D. Thabut, C. Hezode, L. Alric, C. Comarmond, G. Ragab, L. Quartuccio, et al., "Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis", Clinical Gastroenterology and Hepatology, vol. 17, issue 3: W.B. Saunders, pp. 518 - 526, 2019. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
El-Gendy, H., R. M. El-Gohary, S. Mahfouz, H. M. A. Ahmed, D. M. El Demerdash, and G. Ragab, "Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature", Platelets, vol. 30, issue 5: Taylor and Francis Ltd, pp. 664 - 671, 2019. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Alnahas, Z., manal el menyawi, M. Fawzy, O. Shaker, and G. Ragab, "173. 25-HYDROXYVITAMIN D3 DEFICIENCY AND VITAMIN D RECEPTOR POLYMORPHISMS IN EGYPTIAN BEHÇET’S DISEASE PATIENTS: A PILOT STUDY", Rheumatology, vol. 58, issue Supplement_2: Oxford University Press, pp. kez060, 2019. Abstract
n/a
Cacoub, P., S. Nafa Si Ahmed, Y. Ferfar, S. Pol, D. Thabut, C. Hezode, L. Alric, C. Comarmond, G. Ragab, and L. Quartuccio, "Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis", Clinical Gastroenterology and Hepatology, vol. 17, issue 3: WB Saunders, pp. 518-526, 2019. Abstract
n/a
El-Gendy, H., R. M. El-Gohary, S. Mahfouz, H. M. A. Ahmed, D. M. El Demerdash, and G. Ragab, "Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature", Platelets, vol. 30, issue 5: Taylor & Francis, pp. 664-671, 2019. Abstract
n/a
Goubran, H., G. Ragab, and S. Hassouna, Precision Anticoagulation Medicine: A Practical Guide, : Springer Nature, 2019. Abstract
n/a
Hegazy, M. T., A. Fayed, T. El Shabony, M. Visentini, D. Saadoun, P. Cacoub, and G. Ragab, "Relapsing Cryoglobulinemic Vasculitis Following Successful HCV Eradication by Interferon-Free Direct Acting Antivirals, an International Multicenter Study", ARTHRITIS & RHEUMATOLOGY, vol. 71: WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, 2019. Abstract
n/a
2018
Hegazy, M. T., W. R. Allam, M. A. Hussein, N. Zoheir, L. Quartuccio, S. F. El-Khamisy, and G. Ragab, "Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs.", EBioMedicine, vol. 35, pp. 106-113, 2018 Sep. Abstract

Mixed Cryoglobulinemic Vasculitis (MCV) is a prominent extra-hepatic manifestation of Hepatitis C virus (HCV) infection. HCV has been reported to cause B-cell disorders and genomic instability. Here, we investigated B-cell activation and genome stability in HCV-MCV patients receiving the direct antiviral agent, Sofosbuvir, at multiple centers in Egypt. Clinical manifestations in HCV-MCV patients were improved at the end of treatment (EOT), such as purpura (100%), articular manifestations (75%) and neuropathy (68%). Eighteen patients (56%) showed vasculitis relapse after EOT. BAFF and APRIL were higher at EOT and continued to increase one year following treatment onset. Chromosomal breaks were elevated at EOT compared to baseline levels and were sustained at 3 and 6 months post treatment. We report increased expression of DNA genome stability transcripts such as topoisomerase 1 and TDP1 in HCV-MCV patients after treatment, which continued to increase at 12 months from treatment onset. This data suggest that B-cell activation and DNA damage are important determinants of HCV-MCV treatment outcomes.

El-Gendy, H., R. M. El-Gohary, S. Mahfouz, H. M. A. Ahmed, D. M. El Demerdash, and G. Ragab, "Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature.", Platelets, pp. 1-8, 2018 Oct 29. Abstract

Avascular necrosis (AVN) is a devastating condition that is rarely reported in patients with immune thrombocytopenia (ITP). Treatment with steroids remains a major risk factor for developing AVN. However, the incidence of AVN in patients with ITP requiring corticosteroid therapy is much less than that observed with other clinical conditions requiring corticosteroids. ITP is a bleeding disorder but can be also be a pro-thrombotic state via different mechanisms and thus could result in AVN. Among the possible causes of this pro-thrombotic state is the presence of antiphospholipid antibodies (aPLs). In this case, we report a patient with refractory ITP who developed multifocal AVN around the time she acquired new aPLs. We also discuss different mechanisms by which risk of thrombosis is increased in ITP and the relationship between ITP, aPLs and antiphospholipid syndrome.

Ragab, G., W. Ruff, D. Pearson, H. Goubran, and M. Kriegel, "Antiphospholipid syndrome", The Microbiome in Rheumatic Diseases and Infection: Springer International Publishing, pp. 305 - 321, 2018. Abstract
n/a
Hegazy, M. T., W. R. Allam, M. A. Hussein, N. Zoheir, L. Quartuccio, S. F. El-Khamisy, G. Ragab, and M. C. C. the for the study of Vasculitis, "Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs", EBioMedicine, vol. 35: Elsevier B.V., pp. 106 - 113, 2018. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., T. P. Atkinson, and M. L. Stoll, "The microbiome in rheumatic diseases and infection", The Microbiome in Rheumatic Diseases and Infection: Springer International Publishing, pp. 1 - 490, 2018. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., and H. Rizk, "Subacute bacterial endocarditis", The Microbiome in Rheumatic Diseases and Infection: Springer International Publishing, pp. 391 - 401, 2018. Abstract
n/a
Ragab, G., C. Dehner, H. Hamza, and M. Kriegel, "Systemic lupus erythematosus", The Microbiome in Rheumatic Diseases and Infection: Springer International Publishing, pp. 285 - 304, 2018. Abstract
n/a
Ragab, G., P. T. Atkinson, and M. L. Stoll, The Microbiome in Rheumatic Diseases and Infection, : Springer, 2018.
Tourism